1. Failure to Monitor INR → Fatal Internal Hemorrhage (UK Case)

A patient with a mechanical heart valve was placed on warfarin, requiring strict INR monitoring (target range around 2.5–3.5). Initially, the patient was stable and attending routine checks.

What went wrong:

• INR testing became irregular and delayed
• No dose adjustment despite warning symptoms
• Infection (sepsis) increased warfarin sensitivity, but this was not recognized
• No escalation when INR began rising dangerously

Outcome:

• INR eventually exceeded 10 (critically high)
• Patient developed internal bleeding and splenic rupture
• Despite emergency treatment, the patient died

Legal finding:

The court/settlement found breach of duty in failing to maintain a structured INR monitoring system and failing to respond to clinical deterioration.

👉 Key legal principle:

Once warfarin is prescribed, clinicians must actively monitor INR and adjust therapy based on risk changes.

2. Overdose of Heparin → Hemorrhagic Stroke (US Federal Tort Case)

A patient was switched from warfarin to heparin (blood thinner) during hospital treatment.

What went wrong:

• The patient was prescribed 90 mg twice daily instead of 30 mg
• No double-check system prevented dosing error
• No early monitoring of bleeding markers

Outcome:

• Patient developed hemorrhagic stroke
• Permanent neurological damage followed

Legal outcome:

• Government hospital (VA system) was held liable under medical negligence
• Case settled for significant damages (~$420,000+)

👉 Legal principle:

Medication errors in anticoagulation require strict system-based safeguards (double checks, protocols).

3. Inadequate INR Monitoring After Mechanical Valve Surgery (Cardiology Case)

A woman with a mechanical mitral valve required lifelong warfarin therapy.

What went wrong:

• Initial hospital monitoring was appropriate
• After discharge, INR follow-up became inconsistent
• Patient was not properly instructed on monitoring frequency
• No system ensured follow-up testing after missed visits

Outcome:

• INR became dangerously elevated (>24 in some readings)
• Patient suffered massive gastrointestinal and pulmonary bleeding
• Death occurred shortly after emergency admission

Legal allegation:

Failure of both hospital and outpatient cardiology clinic to:

• Ensure INR follow-up system
• Provide structured anticoagulation management plan

👉 Key principle:

Discharge planning for anticoagulants must include enforceable follow-up systems, not just instructions.

4. Failure to Arrange INR Testing → Retroperitoneal Hemorrhage

A patient on long-term warfarin for deep vein thrombosis (DVT) was managed in outpatient primary care.

What went wrong:

• Patient continued receiving prescriptions without INR review
• No reminders or recall system for blood testing
• Confusion between medications (warfarin vs newer anticoagulant)
• No documentation confirming patient compliance with INR checks

Outcome:

• Patient developed retroperitoneal hemorrhage
• Resulted in femoral nerve damage and long-term disability

Legal finding:

The physician was found to have breached duty by:

• Prescribing anticoagulants without confirming INR monitoring
• Failing to educate patient on monitoring necessity

👉 Key principle:

Prescribing warfarin without active monitoring is itself negligent.

5. Failure of Anticoagulation Clinic Communication → Stroke Case

A patient with atrial fibrillation was being managed in a shared-care model:

• GP prescribed warfarin
• Anticoagulation clinic was supposed to adjust doses

What went wrong:

• INR results were not communicated between systems
• Patient attended appointments, but results were not followed up
• No one took responsibility for missed lab values
• Warfarin dose remained inappropriate for weeks

Outcome:

• Patient developed ischemic stroke due to under-anticoagulation
• Severe neurological disability followed

Legal finding:

Court emphasized system failure rather than individual failure, holding both clinic and GP partially liable.

👉 Key principle:

Shared-care anticoagulation requires clear assignment of responsibility—otherwise it becomes negligent fragmentation.

Core Legal Lessons Across All Cases

Across jurisdictions (UK, US, Australia), courts consistently find negligence where:

1. No structured INR monitoring system exists

Warfarin is considered a high-risk drug requiring active surveillance

2. Abnormal INR values are ignored or delayed

Even short delays can be catastrophic

3. Poor communication between hospital–clinic–GP

Fragmented care is a major liability risk

4. No patient education or follow-up system

Patients must be told:

• When to test INR
• What symptoms require urgent review

5. Failure to adjust dose based on changing conditions

(e.g., infection, antibiotics, liver disease)

Final Summary

Anticoagulation clinic negligence cases almost always revolve around monitoring failure rather than prescribing error. Courts treat warfarin as a “high-alert drug,” meaning:

Even small lapses in INR monitoring can become legally significant if they lead to bleeding or clotting events.